University of Genoa | Italy
Anna Maria Pittaluga is a distinguished pharmacologist with a PhD in Pharmacology and Toxicology from the University of Turin (1990), and MSc degrees in Pharmacy (1983) and in Pharmaceutical Chemistry and Technology with honors (1982) from the University of Genova. She has built a long-standing academic career at the University of Genoa, where she has served as Assistant Professor (1993–2003), Associate Professor (2004–2019), and currently as Full Professor of Pharmacology since 2019. Earlier in her career, she gained international research experience as a Research Fellow at the Italian National Research Council (1990–1992) and as a Foreign Research Associate at Collège de France in Paris (1988–1989). Her scientific interests focus on neurotransmitter release mechanisms, receptor interactions, the effects of HIV-1 proteins and chemokines on central neurotransmission, synaptic function in multiple sclerosis, the neuro-immune interface, and the role of nutraceutics in brain health. She has led numerous national and international projects funded by the Italian Ministry of Research, Ministry of Health, and European programs, serving as principal investigator on studies addressing neuroinflammation, depression, synaptopathies, and the gut-brain axis. Proficient in English and French, in addition to her native Italian, Professor Pittaluga has made significant contributions to advancing pharmacological research with strong translational and clinical implications.
Featured Publications
"Correction: Vallarino et al. Healthy Properties of a New Formulation of Pomegranate-Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis"
"Unveiling Niaprazine’s Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent"
"Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis"
"Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic"
"Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720"